City of Hope appoints bone marrow transplant specialist to leadership positions
Click Here to Manage Email Alerts
Marcel van den Brink, MD, PhD, has been appointed president of City of Hope Los Angeles and National Medical Center.
He also will serve as chief physician executive, as well as Deana and Steve Campbell chief physician executive distinguished chair.
“Dr. van den Brink’s extensive clinical and scientific leadership will be a tremendous benefit as we continue to transform as an organization and create even more positive impact for patients everywhere,” Robert Stone, City of Hope’s CEO and Helen and Morgan Chu chief executive officer distinguished chair, said in a press release. “Throughout his career, Dr. van den Brink has maintained an intense focus on converting scientific discoveries into safer and more effective therapies for patients.”
Van den Brink — who will join City of Hope in October — is recognized for his expertise the field of bone marrow transplantation, as well as his understanding of the microbiome and cancer immunotherapy.
He spent the past 24 years at Memorial Sloan Kettering Cancer Center, most recently serving as head of its division of hematologic malignancies.
“It is a tremendous honor to join City of Hope and contribute to its mission to bring leading-edge cancer care to as many patients as possible through excellence in clinical care, education, outreach and research,” van den Brink said in the release.
Michael Caligiuri, MD, the current president of City of Hope National Medical Center, will stay with the institution and transition to focus full time on laboratory research.
Collapse
Press Release
Read more about
Click Here to Manage Email Alerts